MetaVia Inc. share price logo

MetaVia Inc.

NASDAQ: MTVA

Small Cap

$2.97

-0.88

(-22.86%)

as on

MetaVia Inc. Stock Performance

as on May 27, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $2.82
    $3.53
    downward going graph

    5.05%

    Downside

    18.86%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.97
    $19.03
    downward going graph

    67.47%

    Downside

    540.70%

    Upside

    downward going graph

MetaVia Inc. share price movements today

Previous Close
$3.85
Open
$3.37
Volume
2.4M
Day's Low - High
$2.82 - $3.53
52 Week Low - High
$0.97 - $19.03

MetaVia Inc. Historical Returns

1 Month Return
+ 146.79 %
3 Month Return
+ 142.14 %
1 Year Return
-55.68 %
3 Year Return
0 %
5 Year Return
0 %

MetaVia Inc. Stock Fundamentals & Key Indicators

Check MetaVia Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$19.9M

EPS (TTM)

-2.4867

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-195.12%

MetaVia Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of MetaVia Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
NA$19.9MNANA0.00%NA
BUY$39.7B114.3%74.5512.55%NA
BUY$110.3B110.12%25.7735.51%NA
BUY$67.0B28.51%15.629.65%0.5599999999999999%

Stock Returns calculator for MetaVia Inc. Stock including INR - Dollar returns

The MetaVia Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

MetaVia Inc. investment value today

Current value as on today

₹38,436

Returns

-₹61,564

(-61.56%)

Returns from MetaVia Inc. Stock

-₹65,823 (-65.82%)

Dollar Impact

₹4,259 (+4.26%)

Indian Investors' Interest in MetaVia Inc. Stock

Investment in MetaVia Inc. Shares on INDmoney has grown by 5033.33% in the last 30 days, indicating increased investment activity.

Time period: to

Change:5033.33% versus previous 30 day period

Search interest for MetaVia Inc. Stock has increased by 875% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:875% versus previous 30 day period

MetaVia Inc. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
0
0
0
0
-
0
0
Operating Income
-5
-6
-10
-6
-5
-3
-4
-3
-2
-4
EBITDA
-2
-6
-10
-6
-5
-3
-3
-3
-2
-4
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-5
-6
-10
-5
-5
-3
-3
-3
-1
-3
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-5
-6
-10
-5
-5
-3
-3
-3
-1
-3
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

MetaVia Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
Gross Profit
0
0
0
0
0
0
Operating Income
-29
-15
-19
-15
-28
-13
EBITDA
-29
-15
-11
-15
-28
-13
Interest Expense
-
-
2
-
-
-
Depreciation
0
0
0
0
0
0
Income Before Tax
-29
-15
-13
-12
-27
-12
Income Tax Expense
-
-
-
-
-
-
Net Income
-29
-15
-13
-12
-27
-12
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

MetaVia Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-6
-10
-5
-5
-3
-3
-3
-1
-3
Operating Cash Flow
-6
-7
-5
-5
-4
-3
-2
-4
-4
Investing Cash Flow
0
0
-
-
-
0
-
-
-
Financing Cash Flow
-
19
0
0
0
9
0
0
7
Change in Cash
-6
11
-6
-5
-4
6
-3
-3
3

MetaVia Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-33
-15
-21
-29
-15
-13
-12
-27
-12
Operating Cash Flow
-26
-14
-7
-10
-15
-11
-10
-24
-15
Investing Cash Flow
-
0
-6
0
0
0
0
0
0
Financing Cash Flow
21
17
24
6
22
28
0
18
9
Change in Cash
-5
2
11
-3
6
16
-10
-6
-5

Global Institutional Holdings in MetaVia Inc.

Funds
Holdings
Jane Street Group LLC
0%
SG Americas Securities, LLC
0%
BlackRock Inc
0.01%
Geode Capital Management, LLC
0.65%
JPMorgan Chase & Co
0%

Insights on MetaVia Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, MTVA stock has moved up by 33.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, MetaVia Inc. Common Stock has experienced a drawdown of -16.3%, however Alnylam Pharmaceuticals, Inc. Common Stock resisted the overall trend and outperformed by 4.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 5.9% return, outperforming this stock by 60.6%

About MetaVia Inc.

MetaVia Inc., a clinical-stage biotechnology company, focuses on developing novel pharmaceuticals to treat cardiometabolic diseases. The company develops DA-1241, a novel G-Protein-Coupled Receptor 119 agonist with development optionality as a standalone and/or combination therapy that is in Phase 2a clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis, as well as completed Phase 1 clinical trial for the treatment of type 2 diabetes mellitus; and DA-1726, a novel oxyntomodulin analogue functioning as a GLP-1 receptor and glucagon receptor dual agonist, which is in Phase 1 trial for the treatment of obesity. Its therapeutic programs include ANA001, a proprietary oral niclosamide formulation for the treatment of patients with moderate COVID-19; NB-01 for the treatment of painful diabetic neuropathy; NB-02 for the treatment of cognitive impairment; and Gemcabene for the treatment of dyslipidemia. The company has a license agreement with Pfizer Inc. for the research, development, manufacture, and commercialization of Gemcabene; and Dong-A ST, a sole manufacturer for the production of DA-1241 and DA-1726. The company was formerly known as NeuroBo Pharmaceuticals, Inc. and changed its name to MetaVia Inc. in November 2024. MetaVia Inc. is headquartered in Cambridge, Massachusetts.
OrganisationMetaVia Inc.
Headquarters545 Concord Avenue, Cambridge, MA, United States, 02138
IndustryBiotechnology
CEOMr. Hyung Heon Kim
E-voting on sharesClick here to vote

Key Management of MetaVia Inc.

Name

Title

Mr. Hyung Heon Kim

CEO, President & Director

Mr. Marshall H. Woodworth

Chief Financial Officer

Dr. Mi-Kyung Kim

Chief Scientific Officer

Mr. Robert Homolka

Senior Vice President of Clinical Operations

Dr. W. Christopher Fang M.D.

Consulting Chief Medical Officer & Advisor

Mr. Michael C. Pine

Senior Vice President of Business Development Advisor

FAQs

What is MetaVia Inc. share price today?

MetaVia Inc. share price today is $2.97 as on at the close of the market. MetaVia Inc. share today touched a day high of $3.53 and a low of $2.82.

What is the 52 week high and 52 week low for MetaVia Inc. share?

MetaVia Inc. share touched a 52 week high of $19.03 on and a 52 week low of $0.97 on . MetaVia Inc. stock price today i.e. is closed at $2.97,which is 84.39% down from its 52 week high and 207.42% up from its 52 week low.

What is MetaVia Inc.'s market capitalisation today?

MetaVia Inc. market capitalisation is $0.00T as on .

How to invest in MetaVia Inc. Stock (MTVA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for MetaVia Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in MetaVia Inc. Shares that will get you 0.5051 shares as per MetaVia Inc. share price of $2.97 per share as on May 27, 2026 at 8:46 am IST.

What is the minimum amount required to buy MetaVia Inc. Stock (MTVA) from India?

Indian investors can start investing in MetaVia Inc. (MTVA) shares with as little as ₹95.69 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹956.90 in MetaVia Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on MetaVia Inc. share’s latest price of $2.97 as on May 27, 2026 at 8:46 am IST, you will get 3.3670 shares of MetaVia Inc.. Learn more about fractional shares .